11:34 AM EST - Crescita Therapeutics Inc. : Has entered into an exclusive commercialization and development license agreement with Croma Pharma GmbH, a globally acclaimed pharmaceutical company with specializations in medical aesthetics, ophthalmology and orthopaedics for the rights to Pliaglis® in nine countries including Germany, the United Kingdom, Ireland, Switzerland, Brazil, Romania, Belgium, the Netherlands and Luxembourg. Crescita Therapeutics Inc.
shares T.CTX are trading up $0.05 at $0.79.
